Literature DB >> 8364581

Molecular analysis of British facioscapulohumeral dystrophy families for 4q DNA rearrangements.

M Upadhyaya1, P Jardine, J Maynard, J Farnham, M Sarfarazi, C Wijmenga, J E Hewitt, R Frants, P S Harper, P W Lunt.   

Abstract

Facioscapulohumeral muscular dystrophy is an important autosomal dominant neuromuscular disorder that has been localised to 4q35. We have analysed our extensive panel of 45 families with a new DNA marker p13E-11. The findings, based on multiply informative individual meioses and multipoint mapping, suggest that probe p13E-11 is the closest marker for the disorder and it is likely to be located proximal to the disease locus as are all the other present markers. In nine of the ten new mutations studied, a new smaller EcoRI fragment which was not present in either of the parents was detected, indicating that a de novo DNA rearrangement is indeed associated with the development of the disease state. However, in view of the difficulty in defining the size of over 30kb alleles and the recombinant events observed with p13E-11, we suggest that it should be used in combination with another VNTR marker until a close distal flanking marker for this condition is identified or the gene itself is isolated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364581     DOI: 10.1093/hmg/2.7.981

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

1.  Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: diagnostic approach for sporadic and familial cases.

Authors:  E Bakker; M J Van der Wielen; E Voorhoeve; P F Ippel; G W Padberg; R R Frants; C Wijmenga
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

2.  Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD.

Authors:  M Upadhyaya; J Maynard; M T Rogers; P W Lunt; P Jardine; D Ravine; P S Harper
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

3.  High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families.

Authors:  M Zatz; S K Marie; M R Passos-Bueno; M Vainzof; S Campiotto; A Cerqueira; C Wijmenga; G Padberg; R Frants
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

4.  De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1).

Authors:  P E Jardine; M C Koch; P W Lunt; J Maynard; K D Bathke; P S Harper; M Upadhyaya
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

5.  Analysis of the organisation and localisation of the FSHD-associated tandem array in primates: implications for the origin and evolution of the 3.3 kb repeat family.

Authors:  L N Clark; U Koehler; D C Ward; J Wienberg; J E Hewitt
Journal:  Chromosoma       Date:  1996-09       Impact factor: 4.316

6.  Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy.

Authors:  R Tupler; A Berardinelli; L Barbierato; R Frants; J E Hewitt; G Lanzi; P Maraschio; L Tiepolo
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

7.  Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.

Authors:  G Ricci; M Zatz; R Tupler
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

8.  Sequence homology between 4qter and 10qter loci facilitates the instability of subtelomeric KpnI repeat units implicated in facioscapulohumeral muscular dystrophy.

Authors:  S Cacurri; N Piazzo; G Deidda; E Vigneti; G Galluzzi; L Colantoni; B Merico; E Ricci; L Felicetti
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.